WO2012036520A3 - Nouveau composé à action antibiotique et composition antibiotique le comprenant - Google Patents

Nouveau composé à action antibiotique et composition antibiotique le comprenant Download PDF

Info

Publication number
WO2012036520A3
WO2012036520A3 PCT/KR2011/006881 KR2011006881W WO2012036520A3 WO 2012036520 A3 WO2012036520 A3 WO 2012036520A3 KR 2011006881 W KR2011006881 W KR 2011006881W WO 2012036520 A3 WO2012036520 A3 WO 2012036520A3
Authority
WO
WIPO (PCT)
Prior art keywords
compound
antibiotic composition
antibiotically active
active compound
novel
Prior art date
Application number
PCT/KR2011/006881
Other languages
English (en)
Korean (ko)
Other versions
WO2012036520A2 (fr
Inventor
강린우
김정구
안예진
이병무
Original Assignee
건국대학교 산학협력단
대한민국(농촌진흥청장)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 건국대학교 산학협력단, 대한민국(농촌진흥청장) filed Critical 건국대학교 산학협력단
Publication of WO2012036520A2 publication Critical patent/WO2012036520A2/fr
Publication of WO2012036520A3 publication Critical patent/WO2012036520A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/24—Derivatives of thiourea containing any of the groups, X being a hetero atom, Y being any atom
    • C07C335/26—Y being a hydrogen or a carbon atom, e.g. benzoylthioureas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne un nouveau composé actif sur le plan antibiotique et une composition antibiotique comprenant ledit composé. L'invention concerne plus spécifiquement un composé inhibant la synthèse des lipides des microorganismes, ainsi qu'une utilisation du composé.
PCT/KR2011/006881 2010-09-17 2011-09-16 Nouveau composé à action antibiotique et composition antibiotique le comprenant WO2012036520A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100092040A KR101289461B1 (ko) 2010-09-17 2010-09-17 신규한 항생활성 화합물 및 그 화합물을 포함하는 항생 조성물
KR10-2010-0092040 2010-09-17

Publications (2)

Publication Number Publication Date
WO2012036520A2 WO2012036520A2 (fr) 2012-03-22
WO2012036520A3 true WO2012036520A3 (fr) 2012-08-23

Family

ID=45832136

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/006881 WO2012036520A2 (fr) 2010-09-17 2011-09-16 Nouveau composé à action antibiotique et composition antibiotique le comprenant

Country Status (2)

Country Link
KR (1) KR101289461B1 (fr)
WO (1) WO2012036520A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101523305B1 (ko) * 2013-10-11 2015-05-27 건국대학교 산학협력단 신규한 항생활성 화합물 및 그 화합물을 포함하는 항생 조성물
KR101542454B1 (ko) * 2013-10-11 2015-08-06 건국대학교 산학협력단 신규한 항생활성 화합물 및 그 화합물을 포함하는 항생 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003074497A1 (fr) * 2002-03-01 2003-09-12 Pintex Pharmaceutical, Inc. Composes de modulation de pin1 et methodes d'utilisation associees

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003074497A1 (fr) * 2002-03-01 2003-09-12 Pintex Pharmaceutical, Inc. Composes de modulation de pin1 et methodes d'utilisation associees

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CUI, HUAQING ET AL.: "Exploring new inhibitors of Plasmodium falciparum purine nucleoside phosphorylase.", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 45, 14 August 2010 (2010-08-14), pages 5140 - 5149 *
STEBBINS, JOIN L. ET AL.: "A Structure-based Approach to Retinoid X Receptor-a Inhibition.", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 281, no. 24, 2006, pages 16643 - 16648 *

Also Published As

Publication number Publication date
KR101289461B1 (ko) 2013-07-24
WO2012036520A2 (fr) 2012-03-22
KR20120029909A (ko) 2012-03-27

Similar Documents

Publication Publication Date Title
KR20180085042A (ko) 농업, 산업 및 다른 용도를 위한 방부제로서 비스무트-티올
UA107791C2 (en) Pesticidal compositions
MY162411A (en) Crystalline forms of a macrolide, and uses therefor
WO2012042371A3 (fr) Composition pharmaceutique
WO2012065019A3 (fr) Inhibiteurs pyridopyrimidinone de p13k alpha
MY153926A (en) Borinic compositions
AU2011278165A8 (en) Adhesive composition including deacetylated chitosan
WO2011143772A9 (fr) Inhibiteurs de la réplication du vih
WO2011088027A8 (fr) Composés et procédés
MY149433A (en) Nutritional compositions containing punicalagins
EP2261317B8 (fr) Microorganisme produisant un composé cyclique
IL225440A0 (en) Compounds of cyclohexane derivatives, preparations containing them and their uses
WO2012116254A3 (fr) Analogues de chrysophaentine qui inhibent la protéine ftsz
WO2012036523A3 (fr) Nouveau composé à activité antibiotique et composition antibiotique comprenant le composé
MX2012007837A (es) Derivados de oxazolopirimidina 2, 5 - sustituidos.
UA96476C2 (ru) Фармацевтические композиции, которые содержат ирбесартан
WO2012036520A3 (fr) Nouveau composé à action antibiotique et composition antibiotique le comprenant
WO2012015269A3 (fr) Composé électroluminescent organique à base de phosphaphénanthrène-carbazole et dispositif électroluminescent organique comprenant ce dernier
WO2011081383A3 (fr) Composition comprenant un composé de naphtoquinone pour traiter et prévenir la perte d'audition
WO2012036518A3 (fr) Nouveau composé à activité antibiotique et composition antibiotique comprenant le composé
AU2016202526A1 (en) Clostridial toxin pharmaceutical compositions
WO2011141783A3 (fr) Composition pharmaceutique comprenant de l'irbésartan
CA2678339A1 (fr) Dispositif "roller pop"
AU2010905707A0 (en) Clark compound
AU2010905529A0 (en) Clark compound

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11825480

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11825480

Country of ref document: EP

Kind code of ref document: A2